163 related articles for article (PubMed ID: 37004158)
21. [Significance of selective neck dissection in patients with cN0 thyroid carcinoma].
Li ZJ; An CM; Yan DG; Zhang XW; Zhang ZM; Xu ZG; Tang PZ
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):783-6. PubMed ID: 24378103
[TBL] [Abstract][Full Text] [Related]
22. Medullary Thyroid Carcinoma: Do Ultrasonography and F-DOPA-PET-CT Influence the Initial Surgical Strategy?
Brammen L; Niederle MB; Riss P; Scheuba C; Selberherr A; Karanikas G; Bodner G; Koperek O; Niederle B
Ann Surg Oncol; 2018 Dec; 25(13):3919-3927. PubMed ID: 30306375
[TBL] [Abstract][Full Text] [Related]
23. Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center.
Kim SJ; Yun HJ; Shin SJ; Lee YS; Chang HS
Front Endocrinol (Lausanne); 2021; 12():747704. PubMed ID: 34803914
[TBL] [Abstract][Full Text] [Related]
24. Time to calcitonin normalization after surgery for node-negative and node-positive medullary thyroid cancer.
Machens A; Lorenz K; Dralle H
Br J Surg; 2019 Mar; 106(4):412-418. PubMed ID: 30725475
[TBL] [Abstract][Full Text] [Related]
25. Correlation between Ultrasonic Features of Medullary Thyroid Carcinoma and Cervical Lymph Node Metastasis.
Zhu Q; Shao Z; Zhang X; Xu D
Ultrasound Med Biol; 2021 Apr; 47(4):967-972. PubMed ID: 33461772
[TBL] [Abstract][Full Text] [Related]
26. F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients.
Terroir M; Caramella C; Borget I; Bidault S; Dromain C; El Farsaoui K; Deandreis D; Grimaldi S; Lumbroso J; Berdelou A; Hadoux J; Hescot S; Hartl D; Baudin E; Schlumberger M; Leboulleux S
Thyroid; 2019 Oct; 29(10):1457-1464. PubMed ID: 31530235
[No Abstract] [Full Text] [Related]
27. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
[TBL] [Abstract][Full Text] [Related]
28. Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.
Yip DT; Hassan M; Pazaitou-Panayiotou K; Ruan DT; Gawande AA; Gaz RD; Moore FD; Hodin RA; Stephen AE; Sadow PM; Daniels GH; Randolph GW; Parangi S; Lubitz CC
Surgery; 2011 Dec; 150(6):1168-77. PubMed ID: 22136837
[TBL] [Abstract][Full Text] [Related]
29. Does shear wave elastography for medullary thyroid carcinoma predict lateral cervical lymph node metastasis?
Wen X; Li B; Yu X; Huang Y; Cheng W; Su Z
Eur J Radiol; 2022 Jan; 146():110079. PubMed ID: 34864615
[TBL] [Abstract][Full Text] [Related]
30. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for lateral cervical lymph node metastasis in medullary thyroid carcinoma.
Wu F; Zhou T; Lu K; Pan T; Ni Y; Zhao L; Jiang K; Zhang Y; Luo D
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 50(6):730-740. PubMed ID: 35347916
[TBL] [Abstract][Full Text] [Related]
32. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
[TBL] [Abstract][Full Text] [Related]
33. Correlation between preoperative ultrasonic features of medullary thyroid carcinoma and postoperative recurrence.
Zhu Q; Xu D
BMC Cancer; 2021 Apr; 21(1):344. PubMed ID: 33794811
[TBL] [Abstract][Full Text] [Related]
34. Cervical lymph node metastases in papillary thyroid cancer: Preoperative staging with ultrasound and/or computed tomography.
Lu G; Chen L
Medicine (Baltimore); 2022 Mar; 101(9):e28909. PubMed ID: 35244044
[TBL] [Abstract][Full Text] [Related]
35. Ultrasonographic features of cervical lymph node metastases from medullary thyroid cancer: a retrospective study.
Ni X; Xu S; Zhan W; Zhou W
BMC Med Imaging; 2022 Aug; 22(1):151. PubMed ID: 36038830
[TBL] [Abstract][Full Text] [Related]
36. Clinical and pathological analysis of 19 cases of medullary thyroid carcinoma without an increase in calcitonin.
Zhou Q; Yue S; Cheng Y; Jin J; Xu H
Exp Toxicol Pathol; 2017 Oct; 69(8):575-579. PubMed ID: 28552629
[TBL] [Abstract][Full Text] [Related]
37. Utility of serum procalcitonin for screening and risk stratification of medullary thyroid cancer.
Machens A; Lorenz K; Dralle H
J Clin Endocrinol Metab; 2014 Aug; 99(8):2986-94. PubMed ID: 24840813
[TBL] [Abstract][Full Text] [Related]
38. Timing and extension of lymphadenectomy in medullary thyroid carcinoma: A case series from a single institution.
Polistena A; Sanguinetti A; Lucchini R; Galasse S; Monacelli M; Avenia S; Boccolini A; Johnson LB; Avenia N
Int J Surg; 2017 May; 41 Suppl 1():S70-S74. PubMed ID: 28506418
[TBL] [Abstract][Full Text] [Related]
39. Testicular and inguinal lymph node metastases of medullary thyroid cancer: a case report and review of the literature.
Appetecchia M; Barnabei A; Pompeo V; Sentinelli S; Baldelli R; Corsello SM; Torino F
BMC Endocr Disord; 2014 Oct; 14():84. PubMed ID: 25306429
[TBL] [Abstract][Full Text] [Related]
40. [
Rasul S; Hartenbach S; Rebhan K; Göllner A; Karanikas G; Mayerhoefer M; Mazal P; Hacker M; Hartenbach M
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2159-2169. PubMed ID: 29766245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
